Annual Scientific Meeting

Simultaneous Symposia

Symposium 2A: Positioning Therapies in IBD: What's the Initial Treatment Strategy?

Speaker(s)

• 

  Kim Isaacs, MD, PhD, FACG

  Professor of Medicine
  University of North Carolina
  Chapel Hill, NC
• 

  Uma Mahadevan, MD, FACG

  Professor of Clinical Medicine, University of California, San Francisco; Co-Medical Director
  UCSF Center for Colitis and Crohn's Disease
  San Francisco, CA
• 

  David Rubin, MD, FACG

  Joseph B. Kirsner Professor of Medicine; Chief, Section of Gastroenterology, Hepatology and Nutrition; Co-Director, Digestive Diseases Center
  University of Chicago Medicine
  Chicago, IL, US

Presentations:

• 4:45 PM - 5:05 PM

  High-Risk Crohn's Disease – More Options, More Questions?
  Uma Mahadevan, MD, FACG – UCSF Center for Colitis and Crohn's Disease
• 5:05 PM - 5:25 PM

  Low-Risk Crohn's Disease – Do We Need to Do Anything at All?
  Kim L. Isaacs, MD, PhD, FACG – University of North Carolina
• 5:25 PM - 5:45 PM

  High-Risk Ulcerative Colitis – Where Do We Start?
  David T. Rubin, MD, FACG – University of Chicago Medicine
• 5:45 PM - 6:00 PM

  Q&A - Symposium 2A